Literature DB >> 8086871

Treatment of anxiety.

M Lader1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8086871      PMCID： PMC2540896          DOI： 10.1136/bmj.309.6950.321

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

Review 1.  Benzodiazepines. Depressants or antidepressants?

Authors:  J W Tiller; I Schweitzer
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

2.  Self-help materials for anxiety: a randomized controlled trial in general practice.

Authors:  P Donnan; A Hutchinson; R Paxton; B Grant; M Firth
Journal:  Br J Gen Pract       Date:  1990-12       Impact factor: 5.386

Review 3.  Benzodiazepines and human memory: a review.

Authors:  M M Ghoneim; S P Mewaldt
Journal:  Anesthesiology       Date:  1990-05       Impact factor: 7.892

Review 4.  Current status of beta-blocking drugs in the treatment of anxiety disorders.

Authors:  P Tyrer
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 5.  Benzodiazepines, memory and mood: a review.

Authors:  H V Curran
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety.

Authors:  M Raskin; L R Bali; H V Peeke
Journal:  Arch Gen Psychiatry       Date:  1980-01

7.  Fatal poisonings attributed to benzodiazepines in Britain during the 1980s.

Authors:  M Serfaty; G Masterton
Journal:  Br J Psychiatry       Date:  1993-09       Impact factor: 9.319

Review 8.  Psychological treatment of generalised anxiety disorder. A review of the clinical significance of results in outcome studies since 1980.

Authors:  R C Durham; T Allan
Journal:  Br J Psychiatry       Date:  1993-07       Impact factor: 9.319

Review 9.  Moclobemide. A review of its pharmacological properties and therapeutic use in depressive illness.

Authors:  A Fitton; D Faulds; K L Goa
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

10.  Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

Authors:  D V Sheehan; J Ballenger; G Jacobsen
Journal:  Arch Gen Psychiatry       Date:  1980-01
View more
  4 in total

1.  Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace.

Authors:  C Haslam; S Atkinson; S Brown; R A Haslam
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

2.  A qualitative study exploring how GPs decide to prescribe antidepressants.

Authors:  Julia Hyde; Michael Calnan; Lindsay Prior; Glyn Lewis; David Kessler; Deborah Sharp
Journal:  Br J Gen Pract       Date:  2005-10       Impact factor: 5.386

3.  Deciding who gets treatment for depression and anxiety: a study of consecutive GP attenders.

Authors:  Julia Hyde; Jonathan Evans; Debbie Sharp; Tim Croudace; Glynn Harrison; Glyn Lewis; Ricardo Araya
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386

4.  Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial.

Authors:  D M Sharp; K G Power; V Swanson
Journal:  Br J Gen Pract       Date:  2000-12       Impact factor: 5.386
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.